PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Topical application of Tasmannia lanceolata leaf extract (TLE) for 8 weeks alleviated the appearance of stabilized stretch marks in women [PMID:33048421]
Polygodial inhibited cell viability, colony formation, and migration of taxane-resistant CRPC cell lines and induced G0 phase cell cycle arrest in vitro [PMID:36358679]
Polyphenolic-rich extracts reduced the proliferation of colon (HT-29), stomach (AGS), bladder (BL13), and liver (HepG2) cancer cells in vitro [PMID:23017386]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31851503 (2020) — Distinct Drimane Chemotypes in Tasmanian Mountain Pepper (Tasmannia lanceolata): Differences in the Profiles of Pungent Leaf Phytochemicals Associated with Altitudinal Cline. · Journal of agricultural and food chemistry
- 2.PMID: 28657737 (2017) — Structure-Pungency Relationships and TRP Channel Activation of Drimane Sesquiterpenes in Tasmanian Pepper (Tasmannia lanceolata). · Journal of agricultural and food chemistry
- 3.PMID: 33048421 (2021) — Tasmannia lanceolata leaf extract alleviates stretch mark appearance in a randomized, placebo-controlled clinical trial in women and stimulates extracellular matrix synthesis in ex vivo human skin explants. · Journal of cosmetic dermatology
- 4.PMID: 39406142 (2025) — Effects of polyphenols from Tasmannia lanceolata on structural, emulsifying, and antioxidant properties of pea protein. · Food chemistry
- 5.PMID: 36076815